-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$12.00541.71% Upside
Sangamo Therapeutics, Inc. Frequently Asked Questions
-
What analysts cover Sangamo Therapeutics, Inc.?
Sangamo Therapeutics, Inc. has been rated by research analysts at Wedbush, Truist Financial in the past 90 days.